Current Atherosclerosis Reports

, Volume 14, Issue 5, pp 476–483

Evolving Concepts of Oxidative Stress and Reactive Oxygen Species in Cardiovascular Disease

Clinical Trials and Their Interpretations (J Plutzky, Section Editor)

DOI: 10.1007/s11883-012-0266-8

Cite this article as:
Chen, K. & Keaney, J.F. Curr Atheroscler Rep (2012) 14: 476. doi:10.1007/s11883-012-0266-8


Cardiovascular disease (CVD) continues to be a substantial health-care burden, despite recent treatment advances. Oxidative stress has long been regarded as a key pathophysiological mediator that ultimately leads to CVD including atherosclerosis, hypertension and heart failure. Over the past decade, emerging evidence has shifted our understanding of reactive oxygen species (ROS) from its harmful role to being signaling molecules. Here, we reviewed recent advances in our understanding of ROS that mediate the complex process of CVDs, with a focus on major ROS signaling and sources such as mitochondria and Nicotinamide Adenine Dinucleotide Phosphate (NADPH) oxidases.


Reactive oxygen species Oxidative stress Oxidative signaling Cardiovascular disease Oxidative biomarker Antioxidant therapy Atherosclerosis Hypertension 

Copyright information

© Springer Science+Business Media, LLC 2012

Authors and Affiliations

  1. 1.Division of Cardiovascular Medicine, Department of MedicineUniversity of Massachusetts Medical SchoolWorcesterUSA

Personalised recommendations